Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $19,703.28 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.1684
Revenue (TTM): $0.02 M
Dividend Yield: N/A%
ROE: -18.32%
Latest News
-
Piper Sandler and Bernstein Bullish on Roivant Sciences (ROIV)
Thu, Apr 30, 2026 9:41 PM
-
Roivant Sciences Ltd. (ROIV): David Einhorn Trims Stake
Wed, Apr 29, 2026 9:11 PM
-
Roivant Sciences: Moderna Settlement And Brepocitinib Support A Long-Term Buy
Wed, Apr 29, 2026 11:05 AM
-
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman
Mon, Apr 27, 2026 9:15 PM
Key Financials
Financial data not available
